Delving into the Latest Updates on Biosuccess Biotech Co. Ltd. , with Synapse

概览

关联

2

项与 Biosuccess Biotech Co. Ltd. , 相关的临床试验

NCT01795924

/ Terminated临床1/2期

An Open-Label, Phase 1/2 Study of PD-616 and Low-dose Cytarabine in Patients With Untreated or Relapsed/Refractory Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

The purpose of this study is to determine whether PD-616 in combination with low-dose Cytarabine is safe and effective in the treatment of untreated or relapsed/refractory acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (MDS).

开始日期2013-01-01

申办/合作机构

Biosuccess Biotech Co. Ltd. ,

NCT01009931

/ Terminated临床2期IIT

A Phase II Study of 12-O-tetradecanoylphorbol-13-acetate (TPA) Plus Dexamethasone & Choline Magnesium Trisalicylate in the Treatment of Patients With Relapsed/Refractory Acute Myelogenous Leukemia

This phase II trial is studying the side effects and how well giving tetradecanoylphorbol acetate together with dexamethasone and choline magnesium trisalicylate works in treating patients with relapsed or refractory acute myeloid leukemia.

开始日期2011-03-01

申办/合作机构